Industry
153d agoEli Lilly Invests $2.75B in Insilico
The $2.75 billion partnership between Eli Lilly and Insilico Medicine signals a new era where big pharma collaborates with AI firms to accelerate drug discovery worldwide.
The Signal
By integrating machine‑learning models into early‑stage research, the deal could shorten development timelines, lower costs, and broaden access to innovative therapies across diverse markets in the next decade.